Literature DB >> 2259649

Dinucleotide repeat polymorphism at the int-2 proto-oncogene locus (INT2).

M H Polymeropoulos1, H Xiao, D S Rath, C R Merril.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2259649      PMCID： PMC332906     

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  2 in total

1.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.

Authors:  J L Weber; P E May
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

2.  Sequence organization of the human int-2 gene and its expression in teratocarcinoma cells.

Authors:  S Brookes; R Smith; G Casey; C Dickson; G Peters
Journal:  Oncogene       Date:  1989-04       Impact factor: 9.867
  2 in total
  13 in total

1.  11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice.

Authors:  S D Finkelstein; T Hasegawa; T Colby; S A Yousem
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

2.  High-resolution meiotic and physical mapping of the best vitelliform macular dystrophy (VMD2) locus to pericentromeric chromosome 11.

Authors:  B H Weber; G Vogt; H Stöhr; S Sander; D Walker; C Jones
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

3.  Homozygosity by descent for a rare mutation in the myophosphorylase gene is associated with variable phenotypes in a Druze family with McArdle disease.

Authors:  S Iyengar; H Kalinsky; S Weiss; M Korostishevsky; M Sadeh; Y Zhao; K K Kidd; B Bonne-Tamir
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

4.  Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.

Authors:  R F Chuaqui; Z Zhuang; M R Emmert-Buck; L A Liotta; M J Merino
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

5.  Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of mu-calpain as the multiple endocrine neoplasia type 1 gene.

Authors:  J T Pang; S E Lloyd; C Wooding; B Farren; B Pottinger; B Harding; S E Leigh; M A Pook; F J Benham; G T Gillett; R T Taggart; R V Thakker
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

6.  Mapping eight new polymorphisms in 11q13 in the vicinity of multiple endocrine neoplasia type 1: identification of a new distal recombinant.

Authors:  C M Smith; S A Wells; D S Gerhard
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

7.  Linkage analysis in Usher syndrome type I (USH1) families from Spain.

Authors:  C Espinós; C Nájera; J M Millán; C Ayuso; M Baiget; H Pérez-Garrigues; O Rodrigo; C Vilela; M Beneyto
Journal:  J Med Genet       Date:  1998-05       Impact factor: 6.318

8.  Analysis of a second family with hereditary non-chromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q.

Authors:  E C Mariman; S E van Beersum; C W Cremers; F M van Baars; H H Ropers
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

9.  Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations.

Authors:  H Watkins; L Thierfelder; D S Hwang; W McKenna; J G Seidman; C E Seidman
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

10.  Molecular evidence for non-penetrance in Best's disease.

Authors:  B H Weber; D Walker; B Müller
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.